Sesh is developing the next generation of cancer diagnostics. Our company specializes in predictive biomarkers and non-invasive approaches that:
1) Optimize treatment selection for patients
2) Introduce new indications for immunotherapy combinations and monotherapies
3) Add to the repertoire of patient-specific biomarker information diagnostic companies offer in their assay reports

Sesh's innovative approach to technology development prioritizes cancer care improvement and employee satisfaction, quality of life, and personal growth.

Sesh Incorporated

Org chart

Teams

Offices

Sesh Incorporated

Org chart

Teams

Offices

Related companies